Normal tissue considerations and dose-volume constraints in the moderately hypofractionated treatment of non-small cell lung cancer

被引:19
作者
Fleming, Cathy [1 ,2 ]
Cagney, Daniel N. [3 ]
O'Keeffe, Serena [1 ,2 ]
Brennan, Sinead M. [3 ]
Armstrong, John G. [3 ]
McClean, Brendan [1 ]
机构
[1] St Lukes Hosp, St Lukes Radiat Oncol Network, Dept Phys, Dublin, Ireland
[2] Univ Coll Dublin, UCD Sch Phys, Dublin, Ireland
[3] SL Lukes Hosp, Dept Radiat Oncol, SL Lukes Radiat Oncol Network, Dublin, Ireland
关键词
NSCLC; DVCs; Dose-volume constraints; Toxicity; Hypofractionated; CONFORMAL RADIATION-THERAPY; LOCAL TUMOR-CONTROL; ONCOLOGY-GROUP; PHASE-I; CONCURRENT CHEMORADIOTHERAPY; CHEMORADIATION THERAPY; STEREOTACTIC BODY; RADIOTHERAPY; TOXICITY; ESCALATION;
D O I
10.1016/j.radonc.2016.03.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypofractionated radiation therapy (RT) regimes in non-small cell lung cancer (NSCLC) have become increasingly popular with a number of international trials currently underway. The majority of the dose-volume-constraints (DVCs) published in the literature refer to conventional 2 Gy per fraction deliveries. Here relevant organs-at-risk (OARs) are identified and available dose-volume constraint data discussed and summarised for moderately hypofractionated NSCLC regimes. The OARs examined include lung, brachial plexus, heart, oesophagus, airway and spinal cord. Where available the toxicity rates are also reported with all data summarised tabulated to aid its use in the clinic. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:423 / 431
页数:9
相关论文
共 64 条
[1]   Dose Escalated, Hypofractionated Radiotherapy Using Helical Tomotherapy for Inoperable Non-Small Cell Lung Cancer: Preliminary Results of a Risk-Stratified Phase I Dose Escalation Study [J].
Adkison, Jarrod B. ;
Khuntia, Deepak ;
Bentzen, Soren M. ;
Cannon, George M. ;
Tome, Wolfgang A. ;
Jaradat, Hazim ;
Walker, Wendy ;
Traynor, Anne M. ;
Weigel, Tracey ;
Mehta, Minesh P. .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2008, 7 (06) :441-447
[2]   Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma [J].
Allen, AM ;
Czerminska, M ;
Jänne, PA ;
Sugarbaker, DJ ;
Bueno, R ;
Harris, JR ;
Court, L ;
Baldini, EH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03) :640-645
[3]  
[Anonymous], J APPL CLIN MED PHYS
[4]  
[Anonymous], J NATL CANC I
[5]   Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen [J].
Bearz, Alessandra ;
Minatel, Emilio ;
Abu Rumeileh, Imad ;
Borsatti, Eugenio ;
Talamini, Renato ;
Franchin, Giovanni ;
Gobitti, Carlo ;
Del Conte, Alessandro ;
Trovo, Marco ;
Baresic, Tanja .
BMC CANCER, 2013, 13
[6]   Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) [J].
Belderbos, Jose ;
Uitterhoeve, Lon ;
van Zandwijk, Nico ;
Belderbos, Huub ;
Rodrigus, Patrick ;
van de Vaart, Paul ;
Belderbos, Huub ;
Rodrigus, Patrick ;
van de Vaart, Paul ;
Price, Allan ;
van Walree, Nico ;
Legrand, Catherine ;
Dussenneh, Sonia ;
Bartelink, Harry ;
Giaccone, Giuseppe ;
Koning, Caro .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (01) :114-121
[7]   Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy [J].
Belderbos, Jose S. A. ;
Heemsbergen, Wilma D. ;
De Jaeger, Katrien ;
Baas, Paul ;
Lebesque, Joos V. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01) :126-134
[8]  
Bentzen SM, 2000, INT J RADIAT BIOL, V76, P453, DOI 10.1080/095530000138448
[9]   Hypofractionated radical radiotherapy in elderly patients with medically inoperable stage I-II non-small-cell lung cancer [J].
Bonfili, Pierluigi ;
Di Staso, Mario ;
Gravina, Giovanni Luca ;
Franzese, Pietro ;
Buonopane, Sergio ;
Solda, Francesca ;
Festuccia, Claudio ;
Tombolini, Vincenzo .
LUNG CANCER, 2010, 67 (01) :81-85
[10]   Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma [J].
Bradley, J ;
Graham, MV ;
Winter, K ;
Purdy, JA ;
Komaki, R ;
Roa, WH ;
Ryu, JK ;
Bosch, W ;
Emami, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02) :318-328